Product Description: IR820-PTX, an IR-820 (HY-136886)-Paclitaxel (HY-B0015) conjugate, is an amphipathic small molecule prodrug. IR820-PTX effectively inhibits tumor growth via combined photothermal therapy (PTT) and chemotherapy[1][2].
Applications: Cancer-programmed cell death
Formula: C99H112N4NaO21S2+
References: [1]Zhang D, et al. pH- and Enzyme-Sensitive IR820-Paclitaxel Conjugate Self-Assembled Nanovehicles for Near-Infrared Fluorescence Imaging-Guided Chemo-Photothermal Therapy. ACS Appl Mater Interfaces. 2018 Sep 12;10(36):30092-30102./[2]Yu-Xia Luan, et al. Preparation method and application of amphiphilic small molecule prodrug of ir820-ptx combined with photothermal therapy and chemotherapy and its nanoparticles. CN108727353B.
CAS Number: 2250419-19-1
Molecular Weight: 1781.08
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: Fluorescent Dye;Microtubule/Tubulin
Deutsch
English
